Published 2014 | Version v1
Book

DMA mitigates ionizing radiation induced damage in Balb/c mice through Akt/NFκB/PTEN pathway

  • 1. Department of Chemistry, University of Delhi, Delhi (India)
  • 2. Special Centre for Molecular Medicine, Jawaharlal Nehru University, Delhi (India)

Description

Ionizing radiation is associated with massive apoptosis in tumor as well as in radiosensitive organs. DMA, (5-(4-methylpiperazin-1-yl)-2-(2'-(3,4-dimethoxy-phenyl)-5'-benzimidazolyl) a cytoprotective radiomodulator, work in dual mode of action as free radical quencher and modifier of genomic instability caused by radiation. We observed 34% radioprotection with 50 mg/Kg bw intravenous dose of DMA in Balb/c mice at 8 Gy. DMA treatment before irradiation restored the normal crypts and villi architecture in Balb/c mice. The villi height was restored equivalent to control group in DMA treated animals, whereas, it was degenerated in irradiated animals. IR-induced apoptosis was reduced in spleen in presence of DMA as a result of preservation of splenic lymphocytes from radiation. This clearly exhibits the radioprotective ability of DMA to mitigate radiation induced tissue damage. IR-induced S phase check point was overcome by DMA. DMA promoted activation and phosphorylation of GSK3β through the activation of Akt in Balb/c mice. There was reduction in PTEN level in DMA pretreated mice where as it was upregulated in irradiated mice. Relative enhanced kinase activity of Akt was observed in DMA treated Balb/c mice and irradiated A549, MRC5 cell lines. There was no significant radioprotection in DMA treated Akt siRNA transfected cells in comparison to only Akt siRNA transfected cells with increasing dose of radiation. Akt activation was found in a dose-dependent manner by DMA through Luciferase reporter assay. We observed that DMA treated HEK cells transfected with control siRNA, resulted in less early apoptotic cells within 24h, but radiation (5 Gy) treated cells showed 20% early apoptotic cells within 3 h which were reduced to 12% at 3 h, 9% at 6 h and 8% at 24 h in DMA+radiation treated cells determined by Annexin V binding assay. Further molecular mRNA expression analysis of key regulatory genes unveil that DMA inhibited p21 and augmented Akt and Gadd45 in intestine tissue. DMA reversed the radiation-induced damage by induction of antiapoptotic Bcl-2 gene. In conclusion, DMA manifests radioprotective effect through the activation of Akt/PTEN/NFκB pathway along with free radical quenching. (author)

Part of:
Proceedings of the international conference on radiation biology: frontiers in radiobiology - immunomodulation, countermeasures and therapeutics: abstract book, souvenir and scientific programme

Additional details

Publishing Information

Publisher
Institute of Nuclear Medicine and Allied Sciences
Imprint Place
Delhi (India)
Imprint Title
Proceedings of the international conference on radiation biology: frontiers in radiobiology - immunomodulation, countermeasures and therapeutics: abstract book, souvenir and scientific programme
Imprint Pagination
314 p.
Journal Page Range
p. 253

Conference

Title
international conference on radiation biology: frontiers in radiobiology - immunomodulation, countermeasures and therapeutics
Acronym
ICRB-2014
Dates
11-13 Nov 2014
Place
New Delhi (India)

Optional Information